ET Net News Agency, 1 September 2020] Sino Biopharmaceutical Limited (01177) said "Fulvestrant Injection" (brand name: Qingkeyi), a drug used for the treatment of breast cancer developed by the group, ...
Spero Therapeutics (SPRO) gets a Buy on immunology pivot, FDA-approved Utebzi and $105M royalty deal funding SP001. Click ...
While we're excited to reveal Riftbound Vendetta's Helm of Suppression, we're sorry in advance for all of the chaos it's ...
Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone. Entered into a clinical trial collaboration and supply agreement with Bayer ...
Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that ...
Ram Kapoor made an emotional revelation on Lock Upp Season 2, sharing a traumatic experience from his childhood that left the ...
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...
Palisade Bio offers a speculative early-stage opportunity, advancing PALI-2108, a gut-restricted PDE4 inhibitor for UC and ...
Proprietary small-molecule formulation extends beyond conventional ROCK inhibitors to accelerate recovery and improve reproducibility in stem cell and organoid research. MONMOUTH JUNCTION, N.J., July ...
SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, ...
Subcutaneous amivantamab induced rapid and durable responses among patients with HPV-unrelated recurrent or metastatic head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results